Page 940 - Textbook of Pathology, 6th Edition

924 LE cell phenomenon, 79 Leukoplakia, 525-26, 714, 721-22 acute, 343
Lead poisoning, 240-41 Leukotrienes, 138 chronic, 343-45
Lecithin, 639 Lewis experiment, 134 Lymphadenopathy, angioimmunoblastic, 344
Leeuwenhoek, von, 3 Lewy bodies, 885 angiofollicular, 343-44
Legionnaire’s disease, 474 Leydig cell tumour, 713, 749 dermatopathic, 344
Leiomyoblastoma, 559 Leydig cells, 703 HIV-related, 344-45
Leiomyoma, 737 Libman-Sack endocarditis, 444-45 Lymphangioma, 412, 521
epithelioid cell, 559 Lichen planus, 778-79 Lymphangiosarcoma, 414
Leiomyosarcoma, 559, 737-38 Lichen sclerosis et atrophicus, 714, 721-22, 775 Lymphangitis, 97, 410
Leishman, Sir William, 5 Li-Fraumeni syndrome, 213, 759, 860 Lymphatic obstruction, 97, 410
Lentigo, 40, 787 Ligandin, 597 Lymphatic spread of tumours, 200-01
Leonardo da Vinci, 3 Line of separation, 49, 50 Lymphatics, 410-11
Lepra reaction, 159-60 Lines of Zahn, 117 Lymphoblast, 347
Lepromin test, 159 Linitis plastica, 557, 559f, 560f Lymphoblast versus myeloblast, 347t
Leprosy, 157-61 Lipid cell tumour, ovary, 749-50 Lymphocytes, 61, 142, 349
bacterial index (BI) in, 158 Lipiduria, 661 atypical, 352
borderline, 160-61 Lipoblast, 866 differences between T and B, 62t
causative organism of, 157 Lipodystrophy, intestinal, 576 subpopulations of, 61-64
classification of, 159 Lipofuscin, 43 Lymphocytosis, 142, 179, 349
clinical features of, 161 Lipogranuloma, 39, 621 Lymphoedema, 97, 410, 706
histopathology of, 160-61 Lipoid nephrosis, 669-70 Lymphogranuloma venereum (LGV), 186
immunology of, 158-59 Lipoma, 865-66 Lymphoid hyperplasia, 343-44
incidence of, 158 Lipooxygenase pathway, 137-38 angiofollicular, 343-44
indeterminate, 161 Lipopolysaccharides, 110 follicular, 342
lepromatous, 160 Lipoproteins, 339-40 Lymphoid neoplasms, 365-84
lepromatous versus tuberculoid, 159t HDL, 394 classifications, 365-68
multibacillary, 158 LDL, 394 general comments, 368-69
nose, 517 VLDL, 394 Hodgkin’s disease, 369-73
paucibacillary, 158 Liposarcoma, 866-67 peripheral (mature) B cell malignancies,
reactions in, 159-60 Liver, 592-637 374-79
Ridley-Jopling classification, 159 abscess, 614-15 peripheral (mature) T cell malignancies,
Leptocytosis, 293 biopsy, 596 379-80
Leptomeninges, 872 chemical and drug injury, 617-18 precursor (immature) B and T cell
Lesions, definition of, 1 coagulation disorders, 336-37 leukaemia-lymphomas, 373-74
Lethal midline granuloma, 380, 403, 517 CVC, 106-07 Lymphoid series, 347
Letterer Siwe disease, 386 fatty change, 37-39, 621-22 Lymphokines, 138
Leucocytes in health and disease, 347-50 metastasis in, 637 Lymphomas, general, 353-56
Leucocytoclastic vasculitis, 403, 404 normal structure of, 592-93 adult T cell (ATLL), 227-28, 379-80
Leucocytosis, 145, 147-51, 348 tumours and tumours-like lesions, 632-37 bowel,
Leucodema, 522 Liver cell necrosis, types of, 604-05 Burkitt’s, 225, 377-78
Leucoderma, 40 bridging, 612 classifications, 353-54, 365-68, 368t
Leucodystrophy, progressive multifocal, 878 piecemeal, 611 CNS, 889
Leucoerythroblastic reaction, 326 Liver function tests, 593-96, 594t contrasting features of, 373t
Leucopenia, 347-51 Lobar pneumonia, 468-71 cutaneous T cell, 379
INDEX
Leukaemias-lymphomas, Lobule, liver, 592 etiology, 354-55
classifcation of, 353-54 Lock jaw, 180 gut, 559-60
etiology of, 354-55 Löeffler’s endocarditis, 456 Hodgkin’s, 369-73
general aspects, 353-56 Löeffler’s syndrome, 494 nasopharynx, 380
pathogenesis of, 355-56 Loose bodies, joints, 851 non-Hodgkin’s (NHL), 373-80
Leukaemia, lymphoid, 354 Lordosis, 249 pathogenesis, 355-56
acute (ALL), 373-74 Ludwig’s angina, 517 staging of, 372t, 380
ALL versus AML, 375t Lukes-Collins classification, 366 testis, 713
chronic lymphoid (CLL), 375-77 Lung, 461-504 WHO classification of, 368t
etiology of, 354-55 abscess, 475-76 Lymphopenia, 349
FAB classification of, 366t CVC, 106 Lymphopoiesis, 347
hairy cell (HCL), 378-79 fungal infections, 476-77 Lyon hypothesis, 257
pathogenesis of, 355-56 normal structure of, 461-62 Lysosomal components, 138
WHO classification of, 368t oedema, 100-01 Lysosomal storage diseases, 261-62
Leukaemia, myeloid, 354 paediatric disease, 462-65 Lysosomes, 24, 37
acute (AML), 362-65 shock, 113 changes in, 37
AML versus ALL, 375t tuberculosis, 155-57
chronic myeloid (CML), 357-59 tumours, 496-504
classification of AML, 362t Lupus erythematosus (LE) cell, 79 M
etiology of, 354-55 Lupus nephritis, 80t, 675-77
FAB classification of, 362t Lupus vulgaris, 774 M-band, 383
pathogenesis of, 355-56 Lupus, nose, 517 MacCallum’s patch, 441
WHO classification of, 357t Luteal phase defect, 732 Macrocytes, 292, 306
Leukaemoid reaction, 352-53 Lymph nodes, 342-85 Macroglossia, 522
lymphoid, 353 metastatic tumours, 385 Macrophage,
myeloid, 353 structure of, 342 alveolar, 106, 143
versus CML, 354 Lymphadenitis, reactive, 343-45 Macular degeneration, retina, 510